Pharmacokinetics of metformin in pediatric type 2 diabetic and healthy adult subjects.

被引：9
|
作者：
Gao, X
Christensen, M
Burghen, GA
Velasquez-Mieyer, P
Moore, KT
Donahue, SR
Reeves, RA
Turner, KC
机构：
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA
[2] Univ Tennessee, Knoxville, TN 37996 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90526-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P46 / P46
页数：1
相关论文
共 50 条
  • [1] EFFECT OF MULTIPLE DOSES OF ISAVUCONAZOLE ON THE PHARMACOKINETICS OF METFORMIN IN HEALTHY SUBJECTS.
    Desai, A.
    Yamazaki, T.
    Kowalski, D.
    Lademacher, C.
    Pearlman, H.
    Rammelsberg, D.
    Townsend, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S41 - S41
  • [2] POPULATION PHARMACOKINETICS OF PREGABALIN IN PEDIATRIC AND ADULT SUBJECTS WITH PARTIAL ONSET SEIZURES AND HEALTHY VOLUNTEERS TO SUPPORT DOSING IN PEDIATRIC SUBJECTS.
    Chan, P. L.
    Liu, J.
    Marshall, S. F.
    McFadyen, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S26 - S27
  • [3] Pharmacokinetics of extended-release metformin versus immediate-release metformin in healthy subjects.
    Niecestro, RM
    Lukacsko, P
    Lamson, MJ
    Walters, E
    Freidhoff, LT
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1063 - 1063
  • [4] Rimonabant pharmacokinetics in healthy and obese subjects.
    Turpault, S
    Kanamaluru, V
    Lockwood, GF
    Bonnet, D
    Newton, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P50 - P50
  • [5] Effects of genetic variants of organic cation transporter 2 (OCT2) on the pharmacokinetics of metformin in healthy subjects.
    Song, I.
    Shin, H.
    Shim, E.
    Jung, I.
    Kim, W.
    Shon, J.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S84 - S84
  • [6] AN ASSESSMENT OF THE PHARMACOKINETICS OF A LOBEGLITAZONE/METFORMIN FIXED-DOSE COMBINATION TABLET IN HEALTHY SUBJECTS.
    Kim, S-Y
    Jeon, J-Y
    Lee, S.
    Park, S-J
    Kim, M-G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S69 - S70
  • [7] GENETIC POLYMORPHISMS OF OCT2 AND MATE1 HAVE NO INFLUENCE ON PHARMACOKINETICS OF METFORMIN IN HEALTHY SUBJECTS.
    Kim, Y.
    Cho, S.
    Chung, J.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S70 - S70
  • [8] Plasma free fatty acid oscillations in healthy, obese, and Type 2 diabetic subjects.
    Ambler, C
    Mao, CS
    Berman, N
    Ipp, E
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 76A - 76A
  • [9] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF ERTUGLIFLOZIN IN HEALTHY SUBJECTS.
    Kumar, V.
    Sahasrabudhe, V.
    Liang, Y.
    Matschke, K.
    Shi, H.
    Fountaine, R. J.
    Hickman, A.
    Saur, D.
    Terra, S. G.
    Cutler, D. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S47 - S47
  • [10] The pharmacokinetics of tesaglitazar (GALIDA™) in healthy male subjects.
    Ericsson, H
    Samuelsson, S
    Bergstrand, S
    Fryklund, L
    Hamrén, B
    Heijer, M
    Öhman, P
    DIABETOLOGIA, 2003, 46 : A292 - A292
12345